MiNK Therapeutics to Report Q2 2026 Results on August 13

MiNK Therapeutics, Inc. announced it will report its financial results for the second quarter ended June 30, 2026, before the market opens on Thursday, August 13, 2026. The company will host a conference call and webcast at 8:30 AM ET on the same day to discuss the financial results and provide a corporate update. This update will focus on the clinical advancement of agenT-797, including new clinical data for pulmonary injury patients, and details on the launch of its named-patient program.